Clinical Trials in Baltimore

Showing 4041-4060 of 20,142 trials

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

NCT04264442

This study is an open-label extension to evaluate the safety and tolerability of long-term dosing of Losmapimod in patients with FSHD1 who participated in the ReDux4 study.

Facioscapulohumeral Muscular Dystrophy (FSHD)

Fulcrum Therapeutics76 participantsStarted Feb 2020

Irvine, California, United States • Los Angeles, California, United States • Gainesville, Florida, United States +14 more locations

COMPLETEDPhase 2< 1 mile

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

NCT01982448

This is a phase II study randomizing patients with stage I with T1 \> 1.5 cm, stage II or III triple negative breast cancer (TNBC) to preoperative cisplatin versus paclitaxel. The study is designed to evaluate the ability of the Homologous Recombination Deficiency (HRD) assay to predict pathologic response to preoperative chemotherapy.

Triple Negative Breast Cancer

Dana-Farber Cancer Institute147 participantsStarted Apr 2014

Birmingham, Alabama, United States • Indianapolis, Indiana, United States • Baltimore, Maryland, United States +17 more locations

Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)

Cisplatin vs Paclitaxel for Triple Negative Breast Cancer

Find Trials by Condition in Baltimore

SELUTION 4 De Novo Small Vessel IDE Trial

Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients

A Study to Assess Collagenase Clostridium Histolyticum (CCH) in the Treatment of Plantar Fasciitis (PFA)

Study of AC699 in Patients With Estrogen Receptor Positive/Human Epidermal Growth Factor Receptor 2 Negative (ER+/HER2-) Locally Advanced or Metastatic Breast Cancer

Surgery as a Treatment for Medically Intractable Epilepsy

Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

A Prospective Study of Memantine in Patients With Cirrhosis and Liver Cancer

A Phase 1 Study of of Anti-CD7 Allogeneic CAR-T Cell Therapy (WU-CART-007) in Patients With Relapsed or Refractory T-ALL/LBL

A Study of S-892216 in Participants With COVID-19

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

A Safety and Effectiveness Prospective Blinded Clinical Study to Validate xBar System as Monitoring Tool for Anastomotic Leaks Detection

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

A Master Protocol for Orforglipron in Participants With Obstructive Sleep Apnea and Obesity or Overweight

Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

OP5-005 Using Omnipod 5 in Adults With Type 2

CERAMENT™| Bone Void Filler Device Registry

A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis